235 related articles for article (PubMed ID: 37007073)
1. Management of pain in patients with bone metastases.
Jing D; Zhao Q; Zhao Y; Lu X; Feng Y; Zhao B; Zhao X
Front Oncol; 2023; 13():1156618. PubMed ID: 37007073
[TBL] [Abstract][Full Text] [Related]
2. Acupuncture as a Complementary Therapy for Cancer-Induced Bone Pain: A Systematic Review and Meta-Analysis.
Yan Z; MuRong Z; Huo B; Zhong H; Yi C; Liu M; Liu M
Front Pain Res (Lausanne); 2022; 3():925013. PubMed ID: 35978992
[TBL] [Abstract][Full Text] [Related]
3. Translational medicine: cancer pain mechanisms and management.
Delaney A; Fleetwood-Walker SM; Colvin LA; Fallon M
Br J Anaesth; 2008 Jul; 101(1):87-94. PubMed ID: 18492671
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic factors related to cancer-induced bone pain and bone pain relief.
Scarpi E; Calistri D; Klepstad P; Kaasa S; Skorpen F; Habberstad R; Nanni O; Amadori D; Maltoni M
Oncologist; 2014 Dec; 19(12):1276-83. PubMed ID: 25342315
[TBL] [Abstract][Full Text] [Related]
5. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
Zhang H; Lund DM; Ciccone HA; Staatz WD; Ibrahim MM; Largent-Milnes TM; Seltzman HH; Spigelman I; Vanderah TW
Pain; 2018 Sep; 159(9):1814-1823. PubMed ID: 29781960
[TBL] [Abstract][Full Text] [Related]
6. Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases.
Park SH; Eber MR; Widner DB; Shiozawa Y
Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29747461
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. The Analgesic and Antineuroinflammatory Effect of Baicalein in Cancer-Induced Bone Pain.
Hu S; Chen Y; Wang ZF; Mao-Ying QL; Mi WL; Jiang JW; Wu GC; Wang YQ
Evid Based Complement Alternat Med; 2015; 2015():973524. PubMed ID: 26649065
[TBL] [Abstract][Full Text] [Related]
9. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
Candiotti KA; Gitlin MC
Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
Chen L; Zhu L; Wang K; Wang W; Mei XP; Liu T; Zhang FX; Wang W; Chen T; Li YQ
Pain Physician; 2013; 16(6):533-46. PubMed ID: 24284839
[TBL] [Abstract][Full Text] [Related]
11. Managing metastatic bone pain: New perspectives, different solutions.
Zaporowska-Stachowiak I; Łuczak J; Hoffmann K; Stachowiak K; Bryl W; Sopata M
Biomed Pharmacother; 2017 Sep; 93():1277-1284. PubMed ID: 28747002
[TBL] [Abstract][Full Text] [Related]
12. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
[TBL] [Abstract][Full Text] [Related]
13. A Mouse Model of Cancer Induced Bone Pain: From Pain to Movement.
Ji H; Jin X; Zhang Q; Zhou Y; Zhu C; Yang Y; Tang Z; Yu G; Wang C
Front Behav Neurosci; 2022; 16():873750. PubMed ID: 35813592
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effect of quetiapine in a mouse model of cancer-induced bone pain.
Heo MH; Kim JY; Hwang I; Ha E; Park KU
Korean J Intern Med; 2017 Nov; 32(6):1069-1074. PubMed ID: 28103434
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
Forte BL; Slosky LM; Zhang H; Arnold MR; Staatz WD; Hay M; Largent-Milnes TM; Vanderah TW
Pain; 2016 Dec; 157(12):2709-2721. PubMed ID: 27541850
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system: Novel targets for treating cancer induced bone pain.
Sun J; Zhou YQ; Chen SP; Wang XM; Xu BY; Li DY; Tian YK; Ye DW
Biomed Pharmacother; 2019 Dec; 120():109504. PubMed ID: 31627091
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cancer-induced bone pain.
Middlemiss T; Laird BJ; Fallon MT
Clin Oncol (R Coll Radiol); 2011 Aug; 23(6):387-92. PubMed ID: 21683564
[TBL] [Abstract][Full Text] [Related]
18. miR-300 mitigates cancer-induced bone pain through targeting HMGB1 in rat models.
Liu C; Yang J; Liu H; Xia T; Zhang F
Genes Genomics; 2020 Mar; 42(3):309-316. PubMed ID: 31872385
[TBL] [Abstract][Full Text] [Related]
19. Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents.
Patrick DL; Cleeland CS; von Moos R; Fallowfield L; Wei R; Öhrling K; Qian Y
Support Care Cancer; 2015 Apr; 23(4):1157-68. PubMed ID: 25533578
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
